Publications by authors named "Mahmoud Shoukry ElAdawy"
Article Synopsis
- The study aimed to determine if alpha-blockers can improve persistent obstructive symptoms in children with posterior urethral valve (PUV) after valve ablation, despite no existing obstruction.
- It involved 50 male pediatric patients who received either alpha-blockers or a placebo following surgery and were monitored for symptoms and side effects.
- Results showed a significant improvement in obstructive symptoms for the group taking alpha-blockers (90% improvement) and no side effects were reported for either group.
Aims: This study aimed to detect possible risk factors related to upstaging of clinical stage T2 organ-confined (OC) to non-OC (nOC) bladder cancer (BC) following radical cystectomy (RC).
Settings And Design: This was a prospective multicenter study.
Subjects And Methods: This is a multicenter prospective study including 196 Egyptian BC patients undergoing RC from January 2017 to February 2019 at Cairo University, Fayoum University, and Menoufia University.
Aims: The aim of the study was to investigate the relation between baseline prostate volume (PV) and the improvement of lower urinary tract symptoms (LUTS) induced by tamsulosin monotherapy after 2-year follow-up in Egyptian benign prostatic hyperplasia (BPH) patients.
Settings And Design: This was a prospective comparative multicenter study.
Subjects And Methods: Three hundred and eighty-one BPH patients were included in the study from January 2014 to January 2017.
Objectives: The objective is to study the effect of tamsulosin within hours after the first dose and its prediction of the future improvement of LUTS.
Materials And Methods: From May 2016 until August 2017, 340 patients aged over 40 years with benign prostatic hyperplasia (BPH)-related symptoms were prospectively enrolled; 0.4 mg tamsulosin for 3 months was given.